Minority patient participation crucial to Phase 1 clinical trials: Clues to Cancer

Cleveland: May 1, 2013

CLEVELAND, Ohio — Minorities make up roughly 15 percent of the patient population atCase Comprehensive Cancer Center. In 2012, the Phase 1 team at University Hospitals Seidman Cancer Center met its goal of  matching that percentage of minority patients in clinical trials.

Educating the public on the importance of participating in such research has historically been a challenge, especially with minorities. That can be blamed on the legacy of a notorious government experiment known as the Tuskegee Syphilis Study. In its wake came a longstanding distrust within the black community and a reluctance to participate in any type of medical research involving human subjects. Read more